A Comparison of Two Sensor-Augmented Glycemic Control Systems in Persons With Type 1 Diabetes Mellitus: Subcutaneous (SC) Insulin and Glucagon Delivery vs. SC Insulin Only.
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2011
At a glance
- Drugs Insulin aspart (Primary) ; Glucagon
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 23 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Dec 2008 New trial record.